Trade MBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Mustang Bio, Inc. (MBIO) is trading at US$0.55, up 1.91% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$4.39M. Over the past 52 weeks, MBIO has traded between US$0.47 and US$1.85. On Syfe you can trade MBIO with $0 commission and add it to your watchlist.
| Previous close | US$0.54 |
|---|---|
| Market cap | US$4.39M |
| 52-week range | US$0.47 – US$1.85 |
| Volume | 42.27K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Mustang Bio, Inc.
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Waltham, MA.
Year: 2017
Mustang Bio, Inc. (MBIO) stock is trading at US$0.55, +1.91% from the previous close of US$0.54.
The market cap for Mustang Bio, Inc. (MBIO) stock is approximately US$4.39M.
The 52-week high for Mustang Bio, Inc. (MBIO) stock is US$1.85.
The 52-week low for Mustang Bio, Inc. (MBIO) stock is US$0.47.
Mustang Bio, Inc. (MBIO) does not currently pay a dividend.
Stay on top of MBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
